ABCG2 and neoplasm: In contrast, neither dose of MXR had any effect on tumour growth in the BCRP-expressing tumours (Figure 5B), whereas STX140 again completely inhibited growth (P<0.001), and by day 35 resulted in tumour regression to 78% of the original starting volume.